Business Combinations and Asset Acquisitions (Tables)

3 Months Ended

Apr. 01, 2023

Business Combination and Asset Acquisition [Abstract]

Pro Forma Impact of Business Combinations

The following table presents unaudited pro forma information as if the HRA Pharma and Gateway acquisitions had occurred on January 1, 2021 and had been combined with the results reported in our Condensed Consolidated Statements of Operations for the three months ended April 2, 2022 (in millions):

	Three Months Ended
(Unaudited)	April 2, 2022
Net sales	$	1,209.3
Income (loss) from continuing operations	$	10.8